Interestingly, the loss-of-function HSD17B13 variant has been recognized as a hepatoprotective factor of MASLD, and this HSD17B13 rs6834314 G allele was independently correlated with decreasing incidence of liver-related consequences [19]. Here, HSD17B13 is linked to metabolic dysfunction-associated steatotic liver disease.